These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32686938)

  • 1. Generative Network Complex for the Automated Generation of Drug-like Molecules.
    Gao K; Nguyen DD; Tu M; Wei GW
    J Chem Inf Model; 2020 Dec; 60(12):5682-5698. PubMed ID: 32686938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment-based discovery and optimization of BACE1 inhibitors.
    Madden J; Dod JR; Godemann R; Kraemer J; Smith M; Biniszkiewicz M; Hallett DJ; Barker J; Dyekjaer JD; Hesterkamp T
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5329-33. PubMed ID: 20656487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolution of amidine-based brain penetrant BACE1 inhibitors.
    Oehlrich D; Prokopcova H; Gijsen HJ
    Bioorg Med Chem Lett; 2014 May; 24(9):2033-45. PubMed ID: 24704031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening and structure-based discovery of indole acylguanidines as potent β-secretase (BACE1) inhibitors.
    Zou Y; Li L; Chen W; Chen T; Ma L; Wang X; Xiong B; Xu Y; Shen J
    Molecules; 2013 May; 18(5):5706-22. PubMed ID: 23681056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story.
    Stamford A; Strickland C
    Curr Opin Chem Biol; 2013 Jun; 17(3):320-8. PubMed ID: 23683349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-based discovery of BACE1 inhibitors using functional assays.
    Godemann R; Madden J; Krämer J; Smith M; Fritz U; Hesterkamp T; Barker J; Höppner S; Hallett D; Cesura A; Ebneth A; Kemp J
    Biochemistry; 2009 Nov; 48(45):10743-51. PubMed ID: 19799414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-secretase as a target for Alzheimer's disease drug discovery: an overview of in vitro methods for characterization of inhibitors.
    Mancini F; De Simone A; Andrisano V
    Anal Bioanal Chem; 2011 Jun; 400(7):1979-96. PubMed ID: 21503735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JNJ-67569762, A 2-Aminotetrahydropyridine-Based Selective BACE1 Inhibitor Targeting the S3 Pocket: From Discovery to Clinical Candidate.
    Rombouts FJR; Kusakabe KI; Alexander R; Austin N; Borghys H; De Cleyn M; Dhuyvetter D; Gijsen HJM; Hrupka B; Jacobs T; Jerhaoui S; Lammens L; Leclercq L; Tsubone K; Ueno T; Morimoto K; Einaru S; Sumiyoshi H; Van den Bergh A; Vos A; Surkyn M; Teisman A; Moechars D
    J Med Chem; 2021 Oct; 64(19):14175-14191. PubMed ID: 34553934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Based Survey of the Binding Modes of BACE1 Inhibitors.
    Hu H; Chen Z; Xu X; Xu Y
    ACS Chem Neurosci; 2019 Feb; 10(2):880-889. PubMed ID: 30540177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of pyrazole as C-terminus of selective BACE1 inhibitors.
    Zou Y; Xu L; Chen W; Zhu Y; Chen T; Fu Y; Li L; Ma L; Xiong B; Wang X; Li J; He J; Zhang H; Xu Y; Li J; Shen J
    Eur J Med Chem; 2013 Oct; 68():270-83. PubMed ID: 23988410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of biphenylacetamide-derived inhibitors of BACE1 using de novo structure-based molecular design.
    Mok NY; Chadwick J; Kellett KA; Casas-Arce E; Hooper NM; Johnson AP; Fishwick CW
    J Med Chem; 2013 Mar; 56(5):1843-52. PubMed ID: 23374014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
    Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
    J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generative network complex (GNC) for drug discovery.
    Grow C; Gao K; Nguyen DD; Wei GW
    Commun Inf Syst; 2019; 19(3):241-277. PubMed ID: 34257523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of beta-site amyloid precursor protein cleaving enzyme 1 inhibitors by using machine learning methods.
    Singh R; Ganeshpurkar A; Ghosh P; Pokle AV; Kumar D; Singh RB; Singh SK; Kumar A
    Chem Biol Drug Des; 2021 Dec; 98(6):1079-1097. PubMed ID: 34592057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: new approaches to drug discovery.
    Bolognesi ML; Matera R; Minarini A; Rosini M; Melchiorre C
    Curr Opin Chem Biol; 2009 Jun; 13(3):303-8. PubMed ID: 19467915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of BACE1 for therapeutic use in Alzheimer's disease.
    Luo X; Yan R
    Int J Clin Exp Pathol; 2010 Jul; 3(6):618-28. PubMed ID: 20661410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of Extremely Selective Fused Pyridine-Derived β-Site Amyloid Precursor Protein-Cleaving Enzyme (BACE1) Inhibitors with High In Vivo Efficacy through 10s Loop Interactions.
    Ueno T; Matsuoka E; Asada N; Yamamoto S; Kanegawa N; Ito M; Ito H; Moechars D; Rombouts FJR; Gijsen HJM; Kusakabe KI
    J Med Chem; 2021 Oct; 64(19):14165-14174. PubMed ID: 34553947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Versatile Approach to CF3 -Containing 2-Pyrrolidones by Tandem Michael Addition-Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors.
    Mateu N; Ciordia M; Delgado O; Sánchez-Roselló M; Trabanco AA; Van Gool M; Tresadern G; Pérez-Benito L; Fustero S
    Chemistry; 2015 Aug; 21(33):11719-26. PubMed ID: 26140617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a series of selective and cell permeable beta-secretase (BACE1) inhibitors by fragment linking with the assistance of STD-NMR.
    Fang WS; Sun DY; Yang S; Cheng C; Moschke K; Li T; Sun S; Lichtenthaler SF; Huang J; Wang Y
    Bioorg Chem; 2019 Nov; 92():103253. PubMed ID: 31557620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alzheimer disease market.
    Qian X; Hamad B; Dias-Lalcaca G
    Nat Rev Drug Discov; 2015 Oct; 14(10):675-6. PubMed ID: 26388231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.